Leigh Vogel via Getty Images; Carl Court via Getty Images
Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's tariffs affect it.
Leigh Vogel via Getty Images; Carl Court via Getty Images
Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's tariffs affect it.
No comments